Clinical trial NCT05194176: The Effect of Virtual Reality on Pulmonary Recovery and Mobility in Patients With Blunt Chest Trauma
Official title: The Effect of Virtual Reality on Pulmonary Recovery and Mobility in Patients With Blunt Chest Trauma
Study type: INTERVENTIONAL
Overall status: TERMINATED
Phase: NA
Conditions: Blunt Chest Trauma
Keywords: Virtual Reality
Trauma
Pulmonary Recovery
Lead sponsor: Radboud University Medical Center
Sponsor class: OTHER
First posted: 2022-01-18
Enrollment: 27
Sex: ALL
Minimum age (years): 16
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Blunt chest trauma comprises over 10% of all trauma patients presenting to emergency departments worldwide and is the most frequent injury in polytrauma patients. It is associated with high risk (\>10%) of pulmonary complications such as pneumonia. Pillars of treatment are adequate pain relief, respiratory function exercises and rapid mobilisation through physiotherapy. Inadequate pain control can result in restricted ventilatory function and in reduced mobility, both resulting in a higher risk of particularly pulmonary complications. Virtual Reality (VR) might be an easy to use, individualized, and harmless technique that can facilitate pulmonary recovery and aid in the prevention of complications through reducing pain and promoting exercising. The investigators hypothesize that VR improves respiratory function and mobilisation in the post-acute phase of blunt chest trauma by distracting patients from pain and stress, and by stimulating pulmonary and physical exercise.


Eligibility criteria: Inclusion Criteria:

* Admitted to the trauma ward with sustained blunt chest trauma
* Age≥16
* Patient is willing and able to comply with the study protocol

Exclusion Criteria:

* Neurotrauma with GCS ≤13
* History of dementia, seizures, epilepsy
* Severe hearing/visual impairment not corrected
* Head wounds or damaged skin with which comfortable and hygienic use is not possible.
* Stay at intensive care unit (ICU) during current hospital admission.
* Erect position in bed not possible/allowed.

Primary outcomes:
measure: Inspiration volume, mean change from baseline
timeFrame: From baseline to end of treatment at day 5.
measure: Inspiration volume, repeated measures over 5 days
timeFrame: Twice daily from enrollment to day 5 of treatment
Secondary outcomes:
measure: Time spent sitting or standing, mean change from baseline
timeFrame: Continuously from enrollment to end of treatment at day 5.
measure: Length of hospital stay
timeFrame: At end of follow-up, 30 days after discharge
measure: Pulmonary complications during admission
timeFrame: At end of follow-up, 30 days after discharge
measure: Transfers to ICU
timeFrame: At end of follow-up, 30 days after discharge
measure: Readmission within 30 days
timeFrame: At end of follow-up, 30 days after discharge
measure: Pain score during breathing exercise using Visual Analogue Score (VAS)
timeFrame: Daily from baseline to end of treatment at day 5.
measure: Powerless in Daily living questionnaire
timeFrame: Daily from baseline to end of treatment at day 5.
measure: Quality of Recovery-15 questionnaire
timeFrame: Daily from baseline to end of treatment at day 5.
Other outcomes:
Locations:
city: Nijmegen
country: Netherlands
facility: Radboud university medical center
state: Gelderland
Study officials:
References: